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AbstrAct
Despite the fact that a high proportion of elderly stroke patients develop mood 
disorders, the mechanisms underlying late-onset neuropsychiatric and neurocognitive 
symptoms have so far received little attention in the field of neurobiology. In rodents, 
aged animals display depressive symptoms following stroke, whereas young animals 
recover fairly well. This finding has prompted us to investigate the expression of 
serotonin receptors 2A and 2B, which are directly linked to depression, in the brains 
of aged and young rats following stroke. Although the development of the infarct was 
more rapid in aged rats in the first 3 days after stroke, by day 14 the cortical infarcts 
were similar in size in both age groups i.e. 45% of total cortical volume in young rats 
and 55.7% in aged rats. We also found that the expression of serotonin receptor type 
B mRNA was markedly increased in the perilesional area of aged rats as compared to 
the younger counterparts. Furthermore, histologically, HTR2B protein expression in 
degenerating neurons was closely associated with activated microglia both in aged 
rats and human subjects. Treatment with fluoxetine attenuated the expression of 
Htr2B mRNA, stimulated post-stroke neurogenesis in the subventricular zone and 
was associated with an improved anhedonic behavior and an increased activity in 
the forced swim test in aged animals. We hypothesize that HTR2B expression in the 
infarcted territory may render degenerating neurons susceptible to attack by activated 
microglia and thus aggravate the consequences of stroke.
IntroductIon
Stroke is the second-leading global cause of 
death behind heart disease, accounting for 11.13% of 
total deaths worldwide in 2015 [1]. Studies of stroke 
have demonstrated age and gender effects on incidence, 
functional recovery and mortality, not only in humans 
but also in animal models [2-4]. Therefore, studies on 
physiologically complex organisms including rats, mice 
and non-human primates are required to investigate the 
molecular mechanisms of aging in humans, to predict 
human responses to age-related diseases and also the 
response of aged organisms to therapeutic interventions. 
Since epidemiological studies have revealed that human 
stroke occurs more often in old ages (more than 80 years) 
than late middle age (60-79 years) [1], it is advisable to 
use rats of appropriate age to study the behavioral and 
molecular mechanisms underlying functional recovery 
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after stroke in animal model. Therefore, the aged rodent 
model offers a useful tool to investigate the molecular 
pathways and potential novel therapies that may improve 
functional outcome after cerebral ischemia in preclinical 
studies [5].
Post-stroke depression (PSD) is among the most 
frequent neuropsychiatric consequences of stroke. 
Depression also negatively influences stroke outcome 
with increased morbidity, mortality and poorer functional 
recovery [6, 7]. Morphologically, depression is associated 
with atrophy and loss of neurons and glia, which 
contribute to decreased size and function of limbic brain 
regions that control mood and depression, including the 
prefrontal cortex and hippocampus [8].
In addition to an increased risk of mortality, 
depressed patients are more likely to develop coronary 
artery disease, type 2 diabetes and cognitive deficits 
[9-12]. Depression also complicates the prognosis of 
other chronic diseases [13, 14]. However, the biological 
mechanisms underlying depression remains poorly 
understood due to a lack of biomarkers, relatively low 
rates of heritability, and heterogeneity of precipitating 
factors, including stress [15-17]. For example, a recent 
study has linked HTR2b polymorphisms to susceptibility 
to migraine/hypoperfusion without aura in a Spanish 
population [18].
In the normal adult brain, 5-HT receptor mRNA 
is present at high concentrations in the frontal cortex, 
basal ganglia and at lower levels in some components 
of the limbic system (including hippocampus, septum 
and amygdala) [19], while the highest expression of 
5-HT2C receptor is found in the choroid plexus, with 
lower but substantial densities in other regions, lateral 
septal nucleus, subthalamic nucleus, amygdala and parts 
of the hippocampus, substantia nigra, central gray and 
cerebellum [20]. However, 5-HT2C did not show an age-
dependency in post-stroke rats and was, therefore, not 
investigate din this study. 5-HT2B receptor mRNA is 
mainly found in the hippocampus as well as the cortex, 
midbrain and the hypothalamus [21].
At the genetic and cellular level, we previously 
found significant differences in behavioral, cytological and 
genomic responses to injury in aged animals compared 
to younger controls [22-25]. Behaviorally, aged animals 
display depressive symptoms following stroke, whereas 
young animals recover fairly well [26]. This finding has 
been confirmed repeatedly in subsequent studies [25, 27], 
prompting us to investigate the expression of serotonin 
receptors 2A and 2B, which are directly linked to 
depression, in the brains of aged and young rats following 
stroke.
rEsuLts
To facilitate feeding in aged animals during the first 
three days post-stroke, we fed them with moistened, soft 
pellets. Nevertheless, aged animals do lose some weight 
in the first week following stroke. The mortality rate was 
higher for aged rats (33%) than for younger rats (15%) 
during this time.As previously reported, the hematologic 
parameters showed some age-associated differences, 
notably in blood pressure, but the differences were not 
statistically significant in this stroke model [22, 32]. 
Hedonic behavior
Before surgery, 79% of young animals and 75% 
of old animals were hedonic (Figure 1B). After stroke, 
the number of hedonic young animals did not change 
significantly over the 28 days testing period. However, 
in the old group the number of anhedonic animals has 
increased to 42% by day 21 and to 57% by day 28 (Figure 
1B). The fluoxetine treatment however has reduced 
anhedonic behaviour to 35% by day 28 (Figure 1B, dashed 
line). 
Forced swim
The forced swim test (FST) is commonly used 
for assessing antidepressant-like behavior in animal 
models. There are three predominant behaviors in the 
modified FST: immobility, swimming and climbing. The 
effects of lesion (stroke) and anti-depressant treatment 
with fluoxetine are shown in Figure 2. Stroke produced 
a decrease in cumulative activity (i.e. composed of 
swimming, climbing and immobility times) that decreased 
steadily from day 1 to day 28 (Figure 2A). Fluoxetine 
treatment, however, reversed partially the cumulative 
activity (Figure 2A, red line). When analyzed by activity 
type, swimming itself had a modest contribution to 
the total activity index. As expected, stroke led to an 
impairment of climbing activity that reached the lowest 
value at day 21 post-stroke. Likewise, immobility has 
increased steadily from pre-surgery levels to day 21. The 
anti-depressant treatment led to an improvement in the 
swimming behavior mostly (5-fold increase, p=0.001) 
followed by an improvement in immobility (1.8-fold, p= 
0.02) (Figure 2B).
Age-specific post-stroke up-regulation of Htr2B 
mRNA in the peri-infarct area of rats
Immunohistochemistry with NeuN, a marker of 
neuronal nuclei was used to reveal details of the infarcted 
area [27]. Although the development of the infarct was 
more rapid in aged rats in the first 3 days after stroke [31] 
by day 14 the cortical infarcts were similar in size in both 
age groups i.e. 45% of total cortical volume in young rats 
and 55.7% in aged rats (Figure 3A-3C). 
Of the genes possibly involved in post-stroke 
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depression, we found by transcriptomics analysis using 
the Affymetrix platform, that the transcripts encoding 
the serotonin receptor 2B (Htr2b) but not Htr2a were 
upregulated after stroke in the aged rat stroke model. 
The expression also displayed a strong age effect, being 
more strongly upregulated at day 3 in aged than in young 
rats. The Htr2b mRNA levels returned almost to the pre-
stroke level by day 14 [25]. To validate these results, we 
performed RT-qPCR. At day 3 post-strokewe found by RT-
qPCR,a 15-fold up-regulation in the expression of Htr2b 
mRNA, that was 7-fold higher in the lesioned area of aged 
animalsthan in young animals (Figure 3D). Ht2b mRNA 
levels decreased thereafter in the perilesional area in both 
age groups. Fluoxetine treatment, however, caused, by day 
28, a significant increase (1.9-fold) in the Htr2b mRNA 
levels in the perilesional area of aged rats (Figure 3D). 
To determine the phenotype of Htr2B-positive 
cells, we performed double-immunofluorescence staining 
using a mouse antibody against HTR2B (green) and a 
rabbit antibody raised against NeuN (red). We found that 
HTR2B-positive cells were co-localized with NeuN-
positive nuclei at day3 after stroke in aged rat brains 
(Figure 3E, arrows). Although the mRNA expression 
was largely down-regulated by day 14 post-stroke, the 
HTR2B/NeuN protein co-localization persisted in the peri-
infarcted area (Figure 3F, arrows). 
HTR2B is expressed by neurons and astrocytes in 
the peri-infarcted area of human subjects
By chemical immunostaining, the HTR2B receptor 
in human subjects has a perinuclear localization in 
the penumbral region of post-mortem stroke patients 
(Figure 4A, arrows). By immunofluorescence, a similar 
co-localization was observed in the peri-infarcted area 
between HTR2B-positive cells (green) and cells labeled 
by beta III tubulin (red), a marker of mature neuronal 
cells (Figure 4B, arrows). In addition to the neuronal 
co-localization, we also noted the co-localization with 
astrocytes labeled with FITC-GFAP (Figure 4C, arrows) 
in the penumbral region of post-mortem stroke patients. 
However, there was no co-localization with astrocytes 
in the unlesioned, contralateral region of the same post-
stroke patient (Figure 4D, arrowheads).
HTR2B is surrounded by activated microglia in 
the peri-infarcted area of aged rats and human 
subjects
To gain insight into the cellular function of the 
protein, we further performed double-immunofluorescence 
staining for HTR2B and Iba1, a marker of brain microglia. 
In the peri-infarcted area of young animals activated 
microglia (Figure 5A, arrowheads) was seen in close 
association with HTR2B+ neurons (Figure 5A, arrows). 
The close proximity of HTR2B and brain microglia was 
less evident at day 14 post-stroke (Figure 5B). In aged 
rats, however, a co-localization of the microglia marker 
Iba1 with HTR2B-expressing neurons and blood vessels 
(Bv) (Figure 5C) was seen at day 3 post stroke. Despite 
persistent expression of Iba1 in the peri-infarcted territory 
(Figure 5D, inset), the co-localization between Iba1 and 
HtR2B was less evident by day 14 after stroke in aged 
animals (Figure 5D).
In the peri-lesional area of human stroke victims we 
noted numerous phagocytic microglia expressing AIF1 
(Figure 5E, red), co-localized with HTR2B-expressing 
neurons (Figure 5E, green). Furthermore, numerous 
blood vessels were positive for HTR2B (Figure 5F, green, 
arrows) in remote areas with reference to the infarct core.
Table 1: Case demographics for stroke patients. 





1 78 F 6 d IS/ICH CA
2 51 F 36 hrs IS CA
3 68 M 12 hrs IS CA
4 67 M 40 hrs IS CA
5 51 F 36 hrs IS CA
6 NA M 20 hrs IS CA
7 66 M 30 hrs IS CA
8 72 M 8 d IS/SAH CA
9 78 M 18d IS CA
10 88 F 7d IS/SAH CA
11 68 M 27d IS CA
IS indicates ischemic stroke; ICH, intracerebral hemorrhage; 
SAH, subarachnoid hemorrhage; CA, cortical area
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Chronic fluoxetine treatment stimulates post-
stroke neurogenesis in aged animals
Fluoxetine is an antidepressant of the selective 
serotonin reuptake inhibitor (SSRI) family that has a 
recognised clinical efficacy and safety profile [33]. Since 
the underlying mechanism may involve neurogenesis 
[34], we investigated the immunoreactivity of the early 
neuronal marker doublecortin by immunofluorescence in 
the lateral ventricle region of aged rats after stroke. We 
noted vigorous post-stroke neurogenesis as evidenced by 
an increased number (2.2-fold, p = 0.02) of DCX+ cells 
in the aged brains of animals treated with fluoxetine as 
compared to the modest expression in the brains of control 
animals (Figure 6A vs 6B) so that the number of DCX+ in 
treated animals was almost similar to the number of DCX+ 
found in the subventricular zone (SVZ) of young animals 
ipsilateral to stroke (Figure 6C, 6D). 
dIscussIon
Despite the fact that a high proportion of elderly 
stroke patients develop mood symptoms, there is, as 
yet, little insight into the underlying neurobiological 
mechanisms. Following stroke, aged animals exhibit a 
Figure 1: Experimental design and time course of spontaneous activity and hedonic behaviour after stroke.A. Schematic 
overview of the experimental design.B.: Before surgery, 79% of young animals (blue line) and 75% of old animals (red line) were hedonic. 
After stroke, the number of anhedonic animals increased to 42% by day 21 and to 57% by day 28. The fluoxetine treatment however did 
reduce anhedonic behaviour to 35% by day 28 (Figure 1B, red dashed line). ** p < .020.
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depressive behavior especially in the first week post-
stroke. We found that the expression of serotonin receptor 
type B mRNA was markedly increased in the peri-lesional 
area of aged rats as compared to the younger counterparts. 
Further, histologically, HTR2B protein localisation was 
closely associated with degenerating neurons and activated 
microglia both in aged rats and human subjects. 
Aged rats after stroke display a markedly 
depressive behaviour
Following infarction, aged rats are refractory 
to movement and display a loss of appetite, eating and 
drinking a fraction of what young animals consume. 
Indeed, it has previously been demonstrated that aged 
animals lose some weight in the first week following 
stroke [26]. Our previous data showed that this was at least 
partially attributable to the surgical procedure itself during 
Figure 2: Assessment of post-stroke depression in aged animals. A. After stroke, forced swimm cumulative activity decreased 
steadily form day 1 to day 28. Fluoxetine treatment, however, reversed partially the cumulative activity (dashed line). B. By behaviour 
activity type, swimming had a modest contribution to the total activity index. Stroke led to an impairment of climbing activity that reached 
the lowest value at day 21 post-stroke while immobility increased steadily from pre-surgery levels to day 21. The anti-depressant treatment 
led to an improvement in the swimming behaviour mostly (5-fold increase, p = 0.001) followed by an improvement in immobility behaviour 
(1.8-fold, p = 0.02).
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the first 3 days [26, 27, 35], but thereafter it was obviously 
due to a depressive behaviour manifested by the lack of 
interest in sucrose consumption and an increase in the 
immobility time in the forced swim test. This depressive 
behaviour could be due to differentiation of serotoninergic 
neurons in the grey matter [36]. Generally, there is a 
abnormal 5-HT neurotransmission with increasing age 
that contributes to the deterioration of cognitive processes 
in ageing, including depression [37]. It is well known that 
young animals recover readily form stroke. In fact, aged 
animals exibit a delay of several days in their recovey 
[26]. In addition to increased cortical damage in aged 
animals, we believe that young animals simply have better 
homeostatic mechanisms allowing for behavioral recovery 
by functional compensation. However, as we and others 
previously described, this behaviour improves abruptly 
upon exposure to an enriched environment [26, 33, 39]. 
Conversely, keeping the post-stroke aged rats in isolation 
exacerbated the depressive behaviour [26] suggesting 
that depression may be at the core of decreased motility 
and feeding and apathic behaviour [38, 39]. Indeed, 
earlier studies have implicated 5-HT2BRs in anxiety, 
schizophrenia, autism, migraine, and depression [40, 41]. 
Identification of an age-related increase in Htr2B 
mRNA after stroke
The pattern of brain distribution suggests that the 
activation of 5-HT2 receptor subtypes may be implicated 
in the regulation of mood disorders [42]. Indeed we found 
that Htr2B mRNA but not Htr2A mRNA, was robustly 
increased in the perilesional frontal area of aged rats 
suggesting that the interruption in the serotoninergic 
innervation of cortical neurons by stroke may lead to 
an increased expression of Htr2B mRNA and serotonin 
receptors in the motor and frontal cortex.
Despite the wide occurence in the brain, the function 
of the 5-Htr2B receptor is not precisely known. In the 
brain stem, the 5-HT2B receptor modulates the respiratory 
network discharge properties [40] and within the vascular 
system, Ht2B receptors are involved in the regulation 
of the smooth muscle tone [43]. Moreover, because the 
Figure 3: Age-specific post-stroke up-regulation of Htr2B mRNA in the peri-infarct area of rats. A.-C. By day 14 the 
cortical infarcts were similar in size in both age groups i.e. 45% of total cortical volume in young rats and 55.7% in aged rats. D. By RT-
PCR at day 3 post-stroke there was a 15-fold up-regulation in the expression of Htr2b mRNA that was 7-fold higher in the lesioned area of 
aged animals than in young animals ( N = 7/age group). Fluoxetine treatment, however, caused by day 28, a significant increase (1.9-fold) 
in the Htr2b mRNA levels in the perilesional area of aged rats E.. In the perinfarcted area of aged rats HTR2B-positive cells (green) were 
co-localized with NeuN-positive nuclei (red) at day3 after stroke in aged rat brains (arrows). F. Although the mRNA expression was largely 
down-regulated by day14 post-stroke, the HTR2B/NeuN co-localization persisted in the peri-infarcted area of aged rats (arrows). 
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available ligands do not discriminate between type B and 
type C receptors, it may be that many functions attributed 
to the type C receptor could have been fulfilled by the type 
B receptor as well [44]. 
Among the few studies directly addressing the 
function of the Ht2B receptor, it was shown that the Htr2B 
receptor agonist alpha-methyl-5-(2-thienylmethoxy)-
1H-indole-3-ethanamine (BW723C86), increased 
food consumption and elicited anxiolysis in a social 
interaction model [45]. More recently, studies in Htr2B 
KO mice have shown that the Ht2B receptor is required 
for the hyperlocomotion induced by the “club drug” 
3,4-methylenedioxymethamphetamine (MDMA; also 
known as ecstasy) and modulate the release of serotonin 
[5-hydroxytryptamine (5-HT)] stores from nerve terminals 
[46, 47]. 
Cognitive impairment and depression are the 
most commonly reported neuropsychiatric symptoms, 
both occurring in approximately one third of patients 
after stroke [48]. Apathy is most commonly defined as a 
syndrome of diminished goal-directed behavior, emotion, 
and cognition [49]. This occurs in a third of patients after 
stroke as an independent syndrome, although it may also 
occur as a symptom of depression or dementia [50, 51]. 
“Apathetic” PSD, associated with bilateral basal ganglia 
damage, and “affective” PSD, associated to left frontal 
lobe lesions [52]. Moreover, a relationship between apathy 
and hypoperfusion of both frontal lobes after stroke has 
Figure 4: Histochemical localization of HTRB2B in the peri-infarct area of human subjects. By chemical immunostaining, 
the HTR2B receptor in human subjects has a perinuclear localization (A., arrows; Vector blue-grey development) in the penumbral region 
of post-mortem stroke patients. By immunofluorescence, a similar co-localization was observed in the peri-infarcted area between HTR2B-
positive cells (green) and cells labeled by beta III tubulin (red), a marker of mature neuronal cells (B., arrows). In addition to the neuronal 
co-localization, we also noted the co-localization with astrocytes labeled with FITC-GFAP (C., arrows) in the penumbral region of post-
mortem stroke patients. However, there was no co-localization with astrocytes in the unlesioned, contralateral region of the same post-
stroke patient (D., arrowheads).Bar, 100 µm. Abbreviations: PI, periinfarct. 
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Figure 5: HTR2B is co-localized with brain macrophages in the perinfarcted area of aged rats and human subjects. 
A. In the peri-infarcted area of young animals, activated microglia (arrowheads) was seen in close association with HTR2B+ neurons 
(arrows). The close proximity of HTR2B and brain microglia was less evident at day 14 post-stroke B.. C. In aged rats, numerous microglial 
cells immunopositive for IbaI were wrapped around neurons expressing HTR2B (arrowheads), suggesting a pre-phagocytic pathology. 
In addition, a robust co-localization of the microglia marker Iba1 with HTR2B-expressing blood vessels (inset; Bv). D. At day14, the 
co-localization between Iba1 and HtR2B was less evident in aged animals. E. In the peri-lesional area of human stroke victims we noted 
numerous phagocytic microglia expressing AIF1 (red), co-localized with HTR2B-expressing neurons (green). F. In remote areas with 
reference to the infarct core, numerous blood vessels were positive for HTR2B (green, arrows). Bar, 100 µm. Abbreviations: Bv, blood 
vessel; IC, infarct core; PI, periinfarct.
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reported [53, 54]. Since the behavior of our aged rodents 
was more „apathetic“ we hypothesize that the increased 
HT2B mRNA and protein expression in neurons around 
the peri-lesional area was due to the interruption of 
asceding inputs from basal ganglia which normally supply 
neurons in the frontal cortex with biogenic amines like 
5-HT and dopamine. Our hypothesis is supported by 
animal studies reporting an upregulation of Htr2B mRNA 
and protein in response to the serotonergic deafferentation 
to compensate for the loss of serotonin input [55] and 
several clinical studies in elderly patients that reported an 
association between old age and apathy in stroke survivors 
[42, 56, 57] and normal elderly subjects [51]. Furthermore, 
apathy is significantly more represented in late onset 
depression than in early onset depression [58].
Previous studies have described that the selective 
serotonin reuptake inhibitors may have a beneficial effect 
in PSD therapy, but the role of SSRI treatment after stroke 
in aged animals has not been studied. Indeed, fluoxetine 
treatment alleviated the effect of stroke on the anhedonic 
Figure 6: Fluoxetine stimulates post-stroke neurogenesis in aged animals. A.,D. Note the vigorous post-stroke neurogenesis as 
evidenced by an increased number of DCX+ cells in the aged brains of animals treated with fluoxetine (2.2-fold, p = 0.02) as compared to 
the modest expression in the brains of control animals B. so that the number of DCX+ in treated animals was almost similar to the number 
of DCX+ found in the subventricular zone (SVZ) of young animals ipsilateral to stroke C..
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behaviour indicated by an improvement in the swimming 
and immobility behaviour and redressed, to some extent, 
the expression of the Hrt2B mRNA. Our results are 
supported by recent suggestion that serotonin receptors are 
required for fluoxetine to exert its action. Thus, deletion 
of serotonin 1A receptor from the dentate gyrus in the 
hippocampus abolished the anti-depressant activity of 
the drug [59]. In addition, we wanted to exploit the anti-
inflammatory effect of fluoxetine during the subacute 
phase in aged animals [60]. 
Increased cell proliferation and neurogenesis in 
response to chronic but not acute fluoxetine treatment may 
be one mechanism underlying the anti-depressant activity 
of fluoxetine [61]. This mechanism may also occur in the 
aged rats. Indeed, recent work has shown that chronic 
post-stroke treatment with fluoxetine increased the number 
of neuroblasts both in the SVZ and hippocampus of aged 
Wistar rats. However, since fluoxetine treatment did not 
influence either the survival of newly generated cells nor 
the performance in sensorimotor recovery [62] it is not 
currently known whether the newly generated neurons are 
functional in vivo. It has been reported that such neurons 
may be functionally active in hippocampal slices, a model 
very different from an in vivo situation [63].
Whether stroke stimulates endogenous neurogenesis 
is still debated especially in aged subjects where 
neurogenesis is normally decreased [64-68]. Recent data 
indicate that the action of fluoxetine on neurogenesis is 
highly dependent on the age of the treated individual [69]. 
Although several studies suggest no significant influences 
of fluoxetine on neurogenesis in the SVZ [61, 70] of 
experimental animals, it has been shown that stroke per 
se greatly increases neurogenesis in the subventricular 
zone[71]. Moreover, neurogenesis in the subventricular 
zone and nearby striatum after stroke is similar in young 
and old animals, indicating that this potential mechanism 
for self-repair also operates in the aged brain [72]. In 
addition, the beneficial effects of fluoxetine could be 
also due to the pleiotropic anti-inflammatory effect [60, 
73]. Nevertheless, fluoxetine did stimulate post-stroke 
neurogenesis in the SVZ of aged animals and was 
associated with an improved anhedonic behavior and 
an increased activity in the forced swim test. However, 
whether endogenous neurogenesis contributes to an 
improved hedonic behavior has still to be established.
Study limitations 
The variability of injury size and injury location 
following MCAO model is considerably high; (ii) 
extent of fluoxetine treatment beyond 14 days; (iii) since 
fluoxetine may also have an anti-inflammatory effect 
during the subacute phase in aged animals, it is not clear 
in what ways this effect may have impacted post-stroke 
neurogenesis; (iv) mechanistically, we cannot clearly 
distinguish between post-stroke depression and apathy.
concLusIons
Because of the lack of a precise function of the 
HT2B receptor in the brain, we can only speculate about 
the functional significance of the massive upregulation 
of this receptor after stroke in the aged brains. A similar 
upregulation of HT2B receptors has been recently 
reported for amyotrophic lateral sclerosis (ALS), a fatal 
neurodegenerative disorder affecting upper and lower 
motor neurons [67]. Loss of serotoninergic transmission 
led to a compensatory constitutive upregulation of 
Htr2B receptors on motor neurons causing an intrinsic 
hyperexcitability and subsequent spasticity [55]. A 
prolonged neuronal hyperexcitability may also lead to 
degeneration of serotoninergic neurons, and consequently 
attract activated microglia as we consistently observed this 
in the lesioned area of aged animals and autopsy samples 
of stroke patients. Finally, treatment with fluoxetine 
stimulated post-stroke neurogenesis in the SVZ and was 
associated with an improved anhedonic behavior and an 
increased activity in the forced swim test in aged animals.
MAtErIAL And MEtHods
Animals
30 young (3 to 4 mo of age) and 46 aged (19 to 20 
mo) male Sprague-Dawley rats, bred in-house, were used. 
Body weights ranged from 290 to 360 g for the young rats 
and from 520 to 600 g for the aged rats. After behavioural 
testing, the two age groups were divided randomly into 
3-, 14- and 28 day post-stroke survival groups. The group 
sizes for the aged rats were larger to compensate for the 
higher post-ischemic mortality rate. After 14 days post-
stroke the aged group was further divided into a treatment 
group (N = 15) and a control group (N = 13). The numbers 
reported in the results refer to the number of animals 
that survived the surgery and completed the 4-week 
testing period. The rats were kept in standard cages in a 
temperature (22oC), humidity (40–60%), and light period 
(07.00–19.00h) controlled environment and had free 
access to food and water. The Animal Experimentation 
Institutional Animal Care and Use Committee of the 
University of Medicine and Pharmacy Craiova as meeting 
the ethical requirements of the EU legislation on the 
protection of animals used for experimental purposes 
approved all experiments.
Reversible occlusion of the middle cerebral artery
Eighteen hours prior to surgery, rats were deprived 
of food to minimize variability in ischemic damage that 
can result from varying plasma glucose levels [28]. Water 
remained available at all times. In all cases, craniotomy 
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was performed between 9:00 and 13:00. Animals from 
the control and experimental groups were randomly 
subjected to cerebral infarction that was induced by the 
focal interruption of blood flow by transiently lifting the 
middle cerebral artery with a tungsten hook, as previously 
described [27]. To prevent continued perfusion of the 
target region by arterial collaterals, both common carotid 
arteries were then occluded by tightening pre-positioned 
thread loops. Throughout surgery, anaesthesia was 
maintained by spontaneous inhalation of 1-1.5% isoflurane 
in a mixture of 75% nitrous oxide and 25% oxygen. Body 
temperature was maintained at 37°C by a Homeothermic 
Blanket System (Harvard Apparatus) and the tail artery 
was catheterized to allow the continuous measurement 
of blood pressure and the withdrawal of blood samples 
for determination of pH and blood gases (Blutgassystem 
IL 1620, Instrumentation Laboratory, Munich), as well 
as arterial glucose levels (Omnican7 Balance, B. Braun, 
Melsungen). Local changes in blood flow were monitored 
using a laser Doppler device fixed in place using a tiny 
cylinder nearby the occluded artery (Perimed, Stockholm, 
Sweden), and blood gases were measured at several 
timepoints during ischemia. A decrease in the laser 
Doppler signal to <20% of control values was considered 
to indicate successful MCA occlusion. After 90 minutes, 
the hook was released and the common carotid arteries 
were re-opened.
Treatments
Aged rats were given a fine suspension of fluoxetine 
daily, an anti-depressant drug, in saline (10 mg/Kg body 
weight) administered intraperitoneally at day 14 after 
stroke and was continued for two weeks. The control 
group was treated with vehicle (saline). To label newly 
generated cells, all rats were treated with once-daily i.p. 
injections of bromodeoxyuridine (BrdU; 50mg/ kg body 
weight; Sigma, Germany) during the first week post-
stroke, continued at alternating days thereafter for a period 
of 14 days in total.
Behavioural tests
The testing procedure involved two experimenters, 
one who performed the surgery and was in charge of 
handling the animals according to group assignment, and 
another who carried out the behavioural tests and who was 
not aware of the animals’ group assignments.
Forced swim
The forced swim test was used to assess the time 
of active/passive behavior when animals are placed in 
an inescapable cylinder with water (50 cm water depth) 
for 5 min. Time sampling technique was used to rate the 
predominant behavior over a 60-s interval. Active behavior 
was analyzed by three different form of active behavior: 
(1) climbing behavior- upward-directed movements of 
the forepaws along the side of the swim chamber; (2) 
swimming behavior; and (3) immobility, determined as 
absence of any directed movements of animals’ head and 
body was scored during the first 2 min of the test [29].
Hedonic behavior
Sucrose consumption during a period of 24 hours 
was used as a measure of hedonic behavior as described in 
detail previously [30]. Briefly, 4 days before surgery rats 
were given, for 24h, a free choice between two bottles, 
one filled with 2% sucrose solution, the other containing 
tap water. After a break of two days, the rats were primed 
again with 2% sucrose for 24 hrs. To control for potential 
effects of side preference, the position of the bottles was 
switched after 12 h. In order to balance the air temperature 
between the room and the drinking bottles, they were kept 
in the same room where the testing took place. In order 
to decrease stroke variability due to sucrose consumption, 
one day before surgery rats were given tap water. After the 
MCAO was performed, spontaneous activity and hedonic 
behaviour (sucrose and water levels) were monitored 
every seventh day and recorded for 4 weeks (Figure 
1A). Throughout the experiment the two bottles (water 
and sucrose) were switched once per day, to prevent 
possible effects of side preference in drinking behavior. 
Consumption of liquids was evaluated by weighing the 
bottles before and after the test. Sucrose intake was given 
as the amount of consumed sucrose in mg per gram body 
weight [30]. 
Tissue, RNA and protein analysis
Subsequent to a survival time of 3-, 14- and 28 
days, the rats were deeply anesthetized and perfused 
with buffered saline followed by buffered, 4% freshly 
depolymerized paraformaldehyde. The brain was 
removed, post-fixed in buffered 4% paraformaldehyde for 
24 h, cryoprotected in 20% sucrose prepared in 10 mmol/L 
phosphate-buffered saline, flash-frozen in isopentane and 
stored at -70°C until sectioning. For total RNA and protein 
isolation, the rats (N = 7) were perfused with buffered 
saline only, and the brain was cut into 2 mm slices that 
were dipped in 2% 2,3,5-triphenyltetrozolium chloride 
(TTC) solution so that the infarct core could be visualized 
and microdissected under a dissecting microscope as 
previously described [25]. 
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Real Time Quantitative PCR
Total RNA was isolated using TRIzol reagent 
(Invitrogen Life Technologies, Germany), as described 
by the manufacturer, followed by DNase 1 (Ambion) 
digestion and further purification using the RNeasy Mini 
extraction kit (Qiagen, Hilden, Germany). Purified total 
RNA was used for cDNA array assay and real-time PCR 
quantification. 
For real-time PCR, 2µg of total RNA was reverse-
transcribed using random hexamers and the reverse 
transcription reagents supplied by Life Technologies 
(Karlsruhe, Germany). The PCR reaction was set up 
by mixing 10ng of cDNA, primers, and Master mix 
(PeqLab, Germany), and real-time PCR amplification was 
performed as follows: one cycle of 15min at 95°C and 45 
cycles in three steps each (95°C for 30-s, 58°C for 30-s, 
72°C for 30-s) using a real-time PCR cycler (MyiQ Cycler 
Bio-Rad). A standard curve was generated by plotting the 
log10 [target dilution] of template on the X-axis against 
the Ct value from serial dilutions of target DNA on the 
Y-axis. The efficiency of PCR amplification was 98%. 
The relative expression level of Htr2B and Rpl13a (as the 
housekeeping gene) was determined based on the standard 
curve equation generated for each individual gene. 
Immunohistochemistry
Sections (25 µm-thick) were cut on a freezing 
microtome and processed for immunohistochemistry as 
free-floating material using an automatic staining device 
(www.tingomat.com) capable of staining several hundreds 
of sections simultaneously. Briefly, after incubation with 
blocking solutions containing 3% donkey serum/10 
mmol/L PBS/0.3% Tween 20, tissue sections were exposed 
overnight at 4°C to mouse anti-NeuN (1:1000, Millipore, 
Germany) diluted in PBS containing 3% normal donkey 
serum and 0.3% Tween 20. After extensive washing in 
PBS containing 0.3% Tween, sections were incubated 
overnight at 4°C with biotinylated donkey anti-mouse 
IgG (Jackson ImmunoResearch Laboratories, West Grove, 
PA) diluted 1:4000 in PBS containing 1% normal donkey 
serum and 0.3% Tween 20. After washing in PBS, sections 
were incubated for 4 hrs at room temperature in ABC 
Elite reagent (Vectastain Elite Kit, Vector) diluted 1:100 
in PBS containing 0.3% Tween 20. The antibody complex 
was then visualized with 0.025% 3’,3’ diaminobenzidine 
(DAB) and 0.005% hydrogen peroxide in 100 mmol/L Tris 
buffer (pH 7.5). 
Determination of infarct volume
To assess the size of the infarct induced by transient 
focal ischemia, every tenth section was stained NeuN as 
previously described [31]. Briefly, images of the stained 
sections were taken to cover the entire infarcted area, 
which was then calculated as the sum of partial areas using 
Image J. Integration of the resulting partial volumes gave 
the total volume of the ipsilateral hemisphere along with 
the total volume of the cortical infarct; lesion volume was 
then expressed as percent of the hemispheric volume. 
Doublecortin-BrdU double staining
Cryostat, free-floating sections of 25µm were 
fixed in 4% paraformaldehyde for 15 minutes and then 
washed extensively with PBS After incubation in 50% 
Formamide/2X SSC for 2h at 60°C, sections were 
washed again, first in 2x SSC and then in 10x PBS. After 
denaturation in 2N HCL at 37°C for 40 minutes, sections 
were made neutral by adding 0.1M Borate buffer (pH 
8,5). Thereafter sections were incubated sequentially 
with the guinea pig anti-doublecortin (1:2000; Millipore, 
Germany) antibody overnight at 4°C followed by donkey 
anti-guinea pig IgG-biotin (Dianova, Hamburg, Germany) 
and streptavidin Alexa 488 (Life Technologies, Karslruhe, 
Germany). Finally sections were incubated with rat 
anti-BrdU antibody (1:2000, AbD Serotec, Puchheim, 
Germany). BrdU-positive cells were visualized by 
incubating with Cy3-conjugated donkey anti-rat IgG 
(H+L) (1:3000, Dianova, Hamburg, Germany). 
Immunofluorescence on rat brain sections
Sections (25 µm-thick) were cut on a freezing 
microtome and processed for immunohistochemistry as 
free-floating material using an automatic staining device 
(www.tingomat.com). For phenotyping, rat sections were 
blocked and incubated overnight at 4°C either with rabbit 
anti-NeuN (1:1000, Millipore, Germany) or anti-GFAP 
(1:1000, Abcam) or rabbit anti Iba1 (1:3000, WAKO 
Chemie, Germany) diluted in 3% goat serum, 1x PBS 
and 0,2% Tween. After overnight incubation at 4°C, 
sections were washed and incubated with the secondary 
antibody, goat anti-rabbit-CFL 555 (1:1000 dilution, Santa 
Cruz, Heidelberg, Germany). After a short fixation in 4% 
paraformaldehyde, serotonin receptor 2B-expressing 
cells were visualized by incubating sequentially with 
mouse anti-HTR2B (1:2000, Pharmingen) followed by 
goat anti-mouse HRP polymer (1:10 in 1% goat serum; 
Histofine, Nichirei Technology). Finally, cells were stained 
using tyramide-FITC. Then sections were mounted in 
ProLong® Gold Antifade reagent with Hoechst 33342 
(Life Technologies, Karlsruhe, Germany) to stain nuclei. 
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Immunofluorescence on human brain sections
To analyze HTR2B expression after ischemic stroke, 
formalin-fixed, paraffin-embedded archived brain tissue 
blocks containing both cortical lesional and peri-lesional 
areas were selected from 12 stroke patients with a survival 
post-stroke time ranging from 12 h to 7 days. Death 
was attributed to complications such as massive edema 
and brain herniation with rostrocaudal deterioration, or 
cardiovascular arrhythmias. Written informed consent to 
autopsy was obtained for each patient from the relatives 
or their caregivers. Demographic data of patients and 
controls are given in Table 1.
7µm sections were cut and mounted on positively 
charged slides (Superfrost®), then dewaxed and 
rehydrated. Antigen retrieval was performed in heated 
1mM citric acid (pH6) and non-specific antigen binding 
was blocked in 10% goat serum in PBS. Sections were 
exposed to anti-5-HT2BR antibody (1:50, BD Bioscience) 
and either anti-AIF1 antibody (1:100, Abcam) or anti-beta 
III Tubulin antibody (1:1000, Abcam) diluted in 1% goat 
serum in PBS, then detected using Alexa Fluor 488 and 
594 secondary antibodies (Life Technologies). Sections 
were mounted in ProLong® Gold Antifade reagent with 
DAPI (Life Technologies) and visualized on a Leica 
DM6000 fluorescent microscope.
Microscopy
Confocal microscopy images were acquired using 
a Zeiss LSM710 laser-scanning confocal system with 
spectral detection capabilities, and Zen 2010 software 
version 6.0 (Carl Zeiss Microscopy GmbH, Jena, 
Germany) was used for image acquisition and analysis. 
Excitation light was provided by 488, 543, and 634 nm 
laser lines; fluorescence emission was detected at 500-530 
nm for FITC (green), 550-600 nm for CFL 555 (red) and 
360-486 nm for Hoechst (blue) in separate tracks, using a 
confocal aperture of 1 Airy unit. Some of the images were 
acquired as z-stacks and 3D reconstruction was performed.
Cell Quantitation
A quantitative estimate of the number of DCX- and 
BrdU-immunopositive cells was obtained by counting the 
cells in 25-µm-thick sections in volume units measuring 
250µm x 250µm x 10 µm, employing a ‘random-
systematic’ protocol (random start point for a systematic 
series of every 10th section through the infarcted volume) 
as previously described [5]. The area occupied by cells 
of interest was 30% of the total stained area. The relative 
mean number of co-localized cells was then calculated per 
group, time point, and age by multiplying the number of 
cells per section times 3.3 (the counting boxes that were 
quantitated covered one third of the area of each section) 
times the section interval of 10. Because co-localization 
in one confocal plane sometimes may be misleading as 
to the number of cells co-localizing, we counted double-
labeled cells by 3-D reconstruction as described above. 
By rotating the 3-D image, we were able to determine 
precisely the number of co-localized cells [5]. 
Statistical analysis
The age-dependency of anhedonia and the effect of 
treatment on the hedonic behavior were analyzed using 
the Mann Whitney test. The main effect of treatment 
on sucrose and total liquid consumption, forced swim, 
including swimming, climbing and immobility, was 
evaluated by using two-way ANOVA. Cell quantification 
was performed using the t-test. The level of significance 
(two-tailed threshold) was set at p ≤ 0.05. Data are 
presented as mean ± SD for all other data, as indicated for 
each figure.
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